Consequently, patients with CYP3A5 (219-237C>T) CC genotype may experience greater fluctuations in CsA dose adjustment to achieve target concentrations, thereby increasing the risk of CMV infection (25). Here, CYP3A5 is linked to cytomegalovirus infection.